Semaglutide for adults with type 1 diabetes and overweight
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for more than 3 years
- Your body mass index (BMI) is 30 or higher, or at least 27 with a related condition like high blood pressure, high cholesterol, or heart disease
- You have not used a GLP-1 medicine (like Ozempic or Victoza) in the last 6 months
- You are not pregnant, breastfeeding, or planning to become pregnant, and you use effective birth control if you can become pregnant
- You do not have serious liver disease, pancreatitis, cancer (unless in remission for over 5 years), or a history of thyroid problems
- You are not currently in another clinical trial and have not taken an investigational drug in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This Phase 2 study tests semaglutide (a diabetes and weight-related medicine) to see if it can slow or improve diabetic kidney disease in people with type 1 diabetes. You may be able to join if you have type 1 diabetes for at least 5 years and ongoing signs of kidney damage measured in urine tests.
This trial tests a medicine called semaglutide (often used for diabetes) to see if it helps people in Bangladesh who are overweight or obese lose weight. The study will check if the medicine is safe and effective for both people with and without type 2 diabetes.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
Hear when a new Obesity/Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.